glp-1 through insurance CMS Issues Coverage Guidance on Anti-Obesity Drugs Insurance stopped covering your GLP-1?
Description
Lindqvist, M
READ NEXT: Is compounded semaglutide safe to use
One claim per patient, requested within 30 days of the six-month mark
In the SURPASS-2 trial, tirzepatide demonstrated greater HbA1c reduction and weight loss compared to semaglutide 1 mg in type 2 diabetes
Dual eligibles who are denied coverage by Medicare or whose plan does not cover the diabetes drugs that also treats obesity may face challenges accessing the medication needed for weight loss
The approval timeline can stretch from weeks to months, and denial rates remain significant even for eligible patients
